Trial Profile
Short term biological effects of Zoledronate and Letrozole on invasive breast cancer (pre-operative study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Zoledronic acid (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 30 Jan 2014 According to United Kingdom Clinical Research Network record, status changed from active, no longer recruiting to completed.
- 24 Mar 2010 Results presented at the 7th European Breast Cancer Conference.
- 08 Jan 2010 United Kingdom Clinical Research Network reports accrual to date changed from 82% to 74%.